Parschauer Karah Herdman Insider Trading
Get the latest insider transactions of Parschauer Karah Herdman. Parschauer Karah Herdman is EVP and General Counsel in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Evolus, Inc. ($EOLS) and Director in Arcturus Therapeutics Holdings Inc. ($ARCT). Discover the current value of Parschauer Karah Herdman shares.
Address: C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO 94949CA
Parschauer Karah Herdman is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | EVP and General Counsel | 29,997 | 2,187,081.27 |
| EOLS | Evolus, Inc. | Director | 19,313 | |
| ARCT | Arcturus Therapeutics Holdings Inc. | Director | 0 |
Insider Trading Transactions of Parschauer Karah Herdman
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 113.67 | 313 | 35,579 | 29,997 |
| Mar 03 2021 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 5,500 | 0 | 29,561 |
| Mar 03 2021 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 4,636 | 0 | 34,197 |
| Mar 03 2021 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 138.17 | 3,970 | 548,535 | 30,227 |
| Mar 03 2021 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 142.47 | 11,000 | 1,567,170 | 11,000 |
| Feb 09 2021 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Director | Buy | 0.00 | 19,313 | 0 | 19,313 |
| Nov 02 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 54.50 | 9,903 | 539,714 | 33,871 |
| Nov 02 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 100.12 | 9,903 | 991,488 | 24,061 |
| Nov 02 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 54.50 | 9,903 | 539,714 | 25,000 |
| Oct 30 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 54.50 | 97 | 5,287 | 24,065 |
| Oct 30 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 100.00 | 97 | 9,700 | 23,968 |
| Oct 30 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 54.50 | 97 | 5,287 | 34,903 |
| Oct 16 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 88.00 | 325 | 28,600 | 23,968 |
| Oct 13 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 54.50 | 10,000 | 545,000 | 34,293 |
| Oct 13 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 95.00 | 10,000 | 950,000 | 24,293 |
| Oct 13 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 54.50 | 10,000 | 545,000 | 35,000 |
| Oct 07 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 48.43 | 10,000 | 484,300 | 34,293 |
| Oct 07 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 90.00 | 10,000 | 900,000 | 24,293 |
| Oct 07 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 48.43 | 10,000 | 484,300 | 17,000 |
| Sep 24 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 48.43 | 10,000 | 484,300 | 34,293 |
| Sep 24 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 85.00 | 10,000 | 850,000 | 24,293 |
| Sep 24 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 48.43 | 10,000 | 484,300 | 27,000 |
| Aug 19 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 54.50 | 10,000 | 545,000 | 36,663 |
| Aug 19 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 88.44 | 10,000 | 884,400 | 26,663 |
| Aug 19 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 88.39 | 2,370 | 209,484 | 24,293 |
| Aug 19 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 54.50 | 10,000 | 545,000 | 45,000 |
| Jun 24 2020 | ARCT | Arcturus Therapeutics Hol ... | Parschauer Karah Herdman | Director | Option Exercise | 40.70 | 15,000 | 610,500 | 15,000 |
| Jun 22 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 78.22 | 649 | 50,765 | 26,663 |
| May 19 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 74.72 | 2,722 | 203,374 | 27,312 |
| May 08 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 66.26 | 248 | 16,432 | 29,904 |
| Apr 21 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 58.57 | 248 | 14,525 | 30,152 |
| Mar 03 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 7,800 | 0 | 26,884 |
| Mar 03 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 5,634 | 0 | 32,518 |
| Mar 03 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 56.08 | 2,118 | 118,777 | 30,400 |
| Mar 03 2020 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 56.08 | 22,000 | 1,233,760 | 22,000 |
| Jan 24 2020 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Director | Option Exercise | 10.19 | 23,458 | 239,037 | 23,458 |
| Oct 29 2019 | ARCT | Arcturus Therapeutics Hol ... | Parschauer Karah Herdman | Director | Option Exercise | 10.23 | 15,000 | 153,450 | 15,000 |
| Oct 29 2019 | ARCT | Arcturus Therapeutics Hol ... | Parschauer Karah Herdman | Director | Option Exercise | 10.23 | 20,000 | 204,600 | 20,000 |
| Oct 16 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 1,434 | 0 | 19,084 |
| Jul 17 2019 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Director | Option Exercise | 15.99 | 26,163 | 418,346 | 26,163 |
| Jun 24 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 63.48 | 649 | 41,199 | 20,365 |
| Jun 24 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 63.01 | 1,489 | 93,822 | 18,876 |
| Jun 24 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 61.50 | 1,226 | 75,399 | 17,650 |
| Jun 24 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 63.48 | 649 | 41,199 | 20,365 |
| Jun 24 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 63.01 | 1,489 | 93,822 | 18,876 |
| Jun 24 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 61.50 | 1,226 | 75,399 | 17,650 |
| May 07 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 1,434 | 0 | 21,014 |
| Apr 30 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 68.30 | 468 | 31,964 | 19,580 |
| Apr 23 2019 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 64.43 | 248 | 15,979 | 20,048 |
| Aug 21 2018 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 78.53 | 5,000 | 392,650 | 9,181 |
| Jun 21 2018 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 82.77 | 1,226 | 101,476 | 14,181 |
| Jun 20 2018 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 85.31 | 649 | 55,366 | 15,407 |
| May 10 2018 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 60.00 | 1,465 | 87,900 | 16,056 |
| Apr 19 2018 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 1,431 | 0 | 17,521 |
| Jun 21 2017 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Sell | 63.38 | 705 | 44,683 | 8,795 |
| Mar 01 2017 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 2,000 | 0 | 9,500 |
| Mar 01 2017 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 88.80 | 12,000 | 1,065,600 | 12,000 |
| Jun 22 2016 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Buy | 0.00 | 7,500 | 0 | 7,500 |
| Jun 22 2016 | RARE | Ultragenyx Pharmaceutical ... | Parschauer Karah Herdman | EVP and General Couns ... | Option Exercise | 54.50 | 60,000 | 3,270,000 | 60,000 |